Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)
- Jair Bar*
- , Maya Damianovich
- , Goni Hout Siloni
- , Erel Dar
- , Yehudit Cohen
- , Oranit Zadok
- , Yoram Cohen
- , Marina Perelman
- , Iris Barshack
- , Ronit I. Yarden
- , David Simansky
- , Alon Ben Nun
- , Amir Onn
*Corresponding author for this work
- Sheba Medical Center at Tel Hashomer
- Georgetown University
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations